Search Results - Meixiao Zhan
- Showing 1 - 6 results of 6
-
1
Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma by Lei Jiang, Luan Li, Yongzhuang Liu, Meixiao Zhan, Ligong Lu, Shengtao Yuan, Yanyan Liu
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Hypoxia-degradable and long-circulating zwitterionic phosphorylcholine-based nanogel for enhanced tumor drug delivery by Shaojun Peng, Boshu Ouyang, Yongjie Xin, Wei Zhao, Shun Shen, Meixiao Zhan, Ligong Lu
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Association of urinary phthalate metabolites with all-cause and cardiovascular disease mortality among adults with diabetes mellitus: National Health and Nutrition Examination Surv... by Zhihong Wang, Yao Deng, Sikang Gao, Zefang Lin, Zhixiong Zheng, Qin Fang, Meixiao Zhan, Taoping Sun, Guomin Huang, Xuyang Geng
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Temporary vaccination clinic for COVID-19 in Zhuhai, China by Hao Jin, Jing Chu, Wei Zhao, Qiao Ye, Meixiao Zhan, Xiaoling Han, Ligong Lu, Junwei Liu, Zhaohui Li, Min Cui
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China by Zhiqiang Wang, Zhibo Zhang, Yong Li, Li Sun, Dezhen Peng, Danyu Du, Xian Zhang, Luwei Han, Liwen Zhao, Ligong Lu, Hongzhi Du, Shengtao Yuan, Meixiao Zhan
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway by Xiaoying Hou, Hongzhi Du, Xingping Quan, Lei Shi, Qianqian Zhang, Yao Wu, Yang Liu, Jing Xiao, Yong Li, Ligong Lu, Xun Ai, Meixiao Zhan, Shengtao Yuan, Li Sun
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book